Skip to content

Human Epidemiology of Newly Identified Arboviruses

Epidemiology in Humans of New Arbovirusus Sorted Out From Metagenomic Screen in Local Vectors and Animal Hosts.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04954352
Acronym
ARBODOCC
Enrollment
400
Registered
2021-07-08
Start date
2020-01-01
Completion date
2024-12-30
Last updated
2021-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arbovirus Infections, SARS-CoV Infection

Keywords

Patients with arboviral infection compatible signs, Unexplained isolated fever, Neurological infection conditions without any identified etiology, Arbovirus, Arboviral like infectious disease

Brief summary

A local network is being set up to study the impact of arboviruses in our region. It is committed to a one-health approach, in particular with research without a priori for new viruses hosted among vectors and wildlife. The candidates identified by high throughput sequencing approaches will serve as a basis for the development of serological and molecular tools for their detections. These tools will be used to assess the possible circulation of these new viruses in humans in biological collections created within the framework of this project Arbodocc .

Interventions

None listed

Sponsors

UMR ASTRE (CIRAD)
CollaboratorUNKNOWN
Institut Pasteur
CollaboratorINDUSTRY
UMR PCCEI
CollaboratorUNKNOWN
University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 80 Years
Healthy volunteers
Yes

Inclusion criteria

\- Patients admitted at the Monpellier University Hospital for any infectious syndrome compatible with an arboviral infection with samples available

Exclusion criteria

\- Informed consent non obtain for samples used

Design outcomes

Primary

MeasureTime frameDescription
Seroprevalence1 dayDetection of antibodies targeting specific antigens of newly identified arboviruses

Secondary

MeasureTime frameDescription
Molecular detection1 dayDetection of newly identified arboviruses genome

Countries

France

Contacts

Primary ContactYannick Simonin, PhD
yannick.simonin@umontpellier.fr434359114
Backup ContactVincent Foulongne, PhD
v-foulongne@chu-montpellier.fr467 330 254

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026